Section 657.30.2. Definitions.

 For purposes of these rules, the following definitions shall apply:

“Board”   means the Iowa board of pharmacy.

“Committee”   means the Iowa monitoring program for pharmacy professionals committee.

“Contract”   means the written document executed by an applicant or licensee and the committee after the committee receives a report from an approved treatment provider, which establishes the terms for participation in the program.

“Impairment”   means an inability, or significant potential for inability, to practice with reasonable safety and skill as a result of a diagnosed substance use disorder or any diagnosed mental or physical health condition.

“Initial agreement”   means the written document establishing the initial terms for participation in the program.

“Licensee”   means a pharmacist licensed by the board, a pharmacist-intern registered with the board, or a pharmacy technician registered with the board.

“Participant”   means an applicant or licensee who does any of the following: self-reports an impairment to the program, is referred to the program by the board, signs an initial agreement with the committee, or signs a contract with the committee.

“Program”   means the Iowa monitoring program for pharmacy professionals.

“Self-report”   means that an applicant or licensee provides written notification to the program that the applicant or licensee has been, is, or may be impaired. Information related to impairment or a potential impairment which is provided on a license application or renewal form may be considered a self-report.

[ ARC 2834C , IAB 12/7/16, effective 1/11/17]